OOIR: Observatory of International Research

Papers

(The TQCC of Journal of Neurovirology is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
Prevalence and correlates of chronic fatigue syndrome and post-traumatic stress disorder after the outbreak of the COVID-19	113
Persistent COVID-19-associated neurocognitive symptoms in non-hospitalized patients	100
Opsoclonus-myoclonus syndrome, a post-infectious neurologic complication of COVID-19: case series and review of literature	46
Chronic fatigue syndrome: an emerging sequela in COVID-19 survivors?	43
Cognitive dysfunction following COVID-19 infection	37
A case report of simultaneous autoimmune and COVID-19 encephalitis	30
Optic neuritis following SARS-CoV-2 infection	29
Magnetic resonance imaging features of COVID-19-related cranial nerve lesions	29
Potential mechanisms of cerebrovascular diseases in COVID-19 patients	27
Meningoencephalitis associated with COVID-19: a systematic review	26
Acute transverse myelitis after SARS-CoV-2 infection: a rare complicated case of rapid onset paraplegia	25
Neurological features and outcome in COVID-19: dementia can predict severe disease	24
Neurological disease caused by Oropouche virus in northern Brazil: should it be included in the scope of clinical neurological diseases?	21
Viruses, SUMO, and immunity: the interplay between viruses and the host SUMOylation system	18
Collateral damage: Impact of SARS-CoV-2 pandemic in people living with HIV	18
Chronically elevated depressive symptoms interact with acute increases in inflammation to predict worse neurocognition among people with HIV	17
Human microglial models to study HIV infection and neuropathogenesis: a literature overview and comparative analyses	16
Neuropathies and neurological dysfunction induced by coronaviruses	16
A case of trigeminal neuralgia developing after a COVID-19 vaccination	15
iPSC-derived three-dimensional brain organoid models and neurotropic viral infections	15
Neuroinvasive potential of human coronavirus OC43: case report of fatal encephalitis in an immunocompromised host	15
MRI negative myelopathy post mild SARS-CoV-2 infection: vasculopathy or inflammatory myelitis?	15
Association between high proviral load, cognitive impairment, and white matter brain lesions in HTLV-1-infected individuals	14
“Anosmia” the mysterious collateral damage of COVID-19	14
HIV-1C and HIV-1B Tat protein polymorphism in Southern Brazil	14

The importance of thinking about Guillain-Barré syndrome during the COVID-19 pandemic: a case with pure dysautonomic presentation	13
A wide spectrum of neurological manifestations in pediatrics patients with the COVID-19 infection: a case series	13
A comprehensive review of COVID-19 biology, diagnostics, therapeutics, and disease impacting the central nervous system	13
Correlation between cerebrospinal fluid and plasma neurofilament light protein in treated HIV infection: results from the COBRA study	13
Accelerated epigenetic aging in adolescents living with HIV is associated with altered development of brain structures	13
Murine-β-coronavirus-induced neuropathogenesis sheds light on CNS pathobiology of SARS-CoV2	12
COVID-19-associated necrotizing encephalopathy presenting without active respiratory symptoms: a case report with histopathology	12
Low levels of frailty in HIV-positive older adults on antiretroviral therapy in northern Tanzania	12
Autonomic neuropathy as post-acute sequela of SARS-CoV-2 infection: a case report	11
Machine learning prediction of neurocognitive impairment among people with HIV using clinical and multimodal magnetic resonance imaging data	11
Guillain-Barré syndrome associated with COVID-19: a case report study	11
Brain-derived neurotrophic factor (BDNF) is associated with depressive symptoms in older adults with HIV disease	11
Clinical and magnetic resonance imaging patterns of extensive Chikungunya virus–associated myelitis	11
Molecular epidemiology of enteroviruses and predominance of echovirus 30 in an Iranian population with aseptic meningitis	10
Opsoclonus myoclonus ataxia syndrome in severe acute respiratory syndrome coronavirus-2	10
Coronavirus disease (COVID-19) complicated by rhino-orbital-cerebral mucormycosis presenting with neurovascular thrombosis: a case report and review of literature	10
A human-derived 3D brain organoid model to study JC virus infection	10
Cytomegalovirus infection induces Alzheimer’s disease-associated alterations in tau	10
Higher cerebrospinal fluid biomarkers of neuronal injury in HIV-associated neurocognitive impairment	9
CD8+ T cells in the central nervous system of mice with herpes simplex infection are highly activated and express high levels of CCR5 and CXCR3	9
The increased intrathecal expression of the monocyte-attracting chemokines CCL7 and CXCL12 in tick-borne encephalitis	9
Cerebral vasculitis caused by Talaromyces marneffei and Aspergillus niger in a HIV-positive patient: a case report and literature review	9
HIV-1 Tat drives the Fabp4/NF-κB feedback loop in microglia to mediate inflammatory response and neuronal apoptosis	9
Monitoring of HTLV-1-associated diseases by proviral load quantification using multiplex real-time PCR	8
The synthetic opioid fentanyl increases HIV replication and chemokine co-receptor expression in vitro	8
Psychometric utility of the international HIV dementia scale and Montreal Cognitive Assessment in HIV-associated asymptomatic neurocognitive impairment	8
Compassionate-use pocapavir and immunoglobulin therapy for treatment of rituximab-associated enterovirus meningoencephalitis	8
TCA cycle metabolic compromise due to an aberrant S-nitrosoproteome in HIV-associated neurocognitive disorder with methamphetamine use	8
Central nervous system vasculopathy associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): a novel case report from Iran	7
Detection of SARS-coronavirus-2 in the central nervous system of patients with severe acute respiratory syndrome and seizures	7
Neurological manifestations of COVID-19: with emphasis on Iranian patients	7
Correlations between cerebrospinal fluid biomarkers, neurocognitive tests, and resting-state electroencephalography (rsEEG) in patients with HIV-associated neurocognitive disorders	7
Viral protein R polymorphisms in the pathogenesis of HIV-associated acute ischaemic stroke: a case–control study	7
The evaluation expression of non-coding RNAs in response to HSV-G47∆ oncolytic virus infection in glioblastoma multiforme cancer stem cells	7
Hypoactivation in the precuneus and posterior cingulate cortex during ambiguous decision making in individuals with HIV	7
Identification of dysregulated pathways underlying HTLV-1-associated myelopathy/tropical spastic paraparesis through co-expression network analysis	7
Infection of human microglial cell line CHME-3 to study neuropathogenesis of chikungunya virus	7
Refining the risk of HTLV-1-associated myelopathy in people living with HTLV-1: identification of a HAM-like phenotype in a proportion of asymptomatic carriers	7
Herpes simplex encephalitis in patients receiving chemotherapy and whole-brain radiation therapy	6
Rates of cognitive impairment in a South African cohort of people with HIV: variation by definitional criteria and lack of association with neuroimaging biomarkers	6
Brain damage serum biomarkers induced by COVID-19 in patients from northeast Brazil	6
Endolysosome iron restricts Tat-mediated HIV-1 LTR transactivation by increasing HIV-1 Tat oligomerization and β-catenin expression	6
Multiple demyelinating sensory and motor mononeuropathy associated with COVID-19: a case report	6
Revisiting JC virus and progressive multifocal leukoencephalopathy	6
Limbic encephalitis in a COVID-19 patient?	6
The association between benzodiazepine use and greater risk of neurocognitive impairment is moderated by medical burden in people with HIV	6
Gut microbiota dysbiosis is associated with worse emotional states in HIV infection	6
Pembrolizumab treatment of inflammatory progressive multifocal leukoencephalopathy: a report of two cases	6
Mild encephalitis/encephalopathy with a reversible splenial lesion associated with respiratory syncytial virus infection in infants	6
Unexpected worsening of progressive multifocal leucoencephalopathy following COVID-19 pneumonia	6

Progressive multifocal leukoencephalopathy and Creutzfeldt-Jakob disease: population-wide incidences, comorbidities, costs of care, and outcomes	6
Neuroimaging and immunological features of neurocognitive function related to substance use in people with HIV	6
Brain tissue transcriptomic analysis of SIV-infected macaques identifies several altered metabolic pathways linked to neuropathogenesis and poly (ADP-ribose) polymerases (PARPs) as potential therapeut	6
Illuminating the in vitro effects of Epstein-Barr virus and vitamin D on immune response in multiple sclerosis patients	6
Pain, psychoaffective symptoms, and quality of life in human T cell lymphotropic virus type 1 (HTLV-1): a cross-sectional study	6